We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 04, 2020

Short-Term, Intensive Chemoresection vs Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
The DaBlaCa-13 Study: Short-Term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer—A Randomised Controlled Trial
Eur Urol 2020 Jul 28;[EPub Ahead of Print], MS Lindgren, P Bue, N Azawi, L Blichert-Refsgaard, MO Sundelin, L Dyrskjøt, JB Jensen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading